Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMay 16, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 16, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 14, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 13, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 12, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMay 5, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 1, 2014View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Mar 21, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 21, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 10, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 5, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 24, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 24, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 19, 2014View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-89

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information